Jeremias M.
- Country
- Germany
- Department
- #5003:Klinik fuer Neurologie
Research Overview
- Long-Term Safety Evaluation of KYV-101 in Patients with Lupus Nephritis, Systemic Sclerosis, Myasthenia Gravis, Rheumatoid Arthritis, or Stiff Person Syndrome
- Phase 2 Multicenter Study of KYV-101 Anti-CD19 CAR T-Cell Therapy in Refractory Generalized Myasthenia Gravis
- Evaluation of KYV-101 Anti-CD19 CAR T-Cell Therapy in Refractory Primary and Secondary Progressive Multiple Sclerosis: A Phase 2 Randomized Study
Data & Insights
Has run more than one trial at 7 of 23 partner sites.
Specializations
Neurological Disorders
The investigator specializes in treating complex neurological conditions, with particular emphasis on multiple sclerosis in its various forms, including primary progressive and secondary progressive variants.
- Progressive Multiple Sclerosis Management
- Relapsing Multiple Sclerosis Treatment
- Breakthrough Disease Activity
Their work encompasses innovative approaches for patients who have not responded to conventional treatments.
Immunological Therapeutics
The investigator focuses on advanced immunotherapy approaches, particularly CAR T-cell therapy applications in neurological conditions. Their expertise includes targeting CD19 mechanisms in autoimmune disorders.
- Anti-CD19 Therapeutic Applications
- Cellular Kinetics Studies
- Novel Immunotherapy Approaches
Their research explores innovative cellular therapy applications in treatment-resistant conditions.
Neuromuscular Disorders
The investigator has developed expertise in treating refractory generalized myasthenia gravis, focusing on novel therapeutic approaches for patients with treatment-resistant forms of the condition.
- Myasthenia Gravis Management
- Refractory Disease Treatment
- Advanced Therapeutic Strategies
Their work addresses complex cases that have not responded to traditional treatment methods.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.